Stryker Corporation (SYK)

NYSE Health Care Health Care Equipment S&P 500

$325.87

-9.21 (-2.75%)

Close of Nov 06, 2026 · end-of-day data

Source: Stryker Corporation's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 02, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$11.32B	$12.44B	$13.60B	$14.88B	$14.35B	$17.11B	$18.45B	$20.50B	$22.59B	$25.12B
Cost of revenue	$3.82B	$4.26B	$4.66B	$5.19B	$5.29B	$6.14B	$6.87B	$7.44B	$8.15B	$9.05B
Gross profit	$7.50B	$8.18B	$8.94B	$9.70B	$9.06B	$10.97B	$11.58B	$13.06B	$14.44B	$16.07B
Research & development	$715.00M	$787.00M	$862.00M	$971.00M	$984.00M	$1.24B	$1.45B	$1.39B	$1.47B	$1.62B
Selling, general & admin	$4.14B	$4.55B	$5.10B	$5.36B	$5.36B	$6.43B	$6.39B	$7.11B	$7.68B	$8.65B
Operating income	$2.17B	$2.30B	$2.54B	$2.71B	$2.22B	$2.58B	$2.84B	$3.89B	$3.69B	$4.89B
Interest expense	$228.00M	$247.00M	$264.00M	$287.00M	$315.00M	$337.00M	$337.00M	$363.00M	$409.00M	$607.00M
Pre-tax income	$1.92B	$2.06B	$2.36B	$2.56B	$1.95B	$2.28B	$2.68B	$3.67B	$3.49B	$4.51B
Income tax	$274.00M	$1.04B	-$1.20B	$479.00M	$355.00M	$287.00M	$325.00M	$508.00M	$499.00M	$1.27B
Net income	$1.65B	$1.02B	$3.55B	$2.08B	$1.60B	$1.99B	$2.36B	$3.17B	$2.99B	$3.25B
EBITDA	$2.93B	$3.16B	$3.50B	$3.76B	$3.30B	$3.86B	$4.12B	$5.23B	$5.12B	$6.46B
EPS (basic)	$4.40	$2.73	$9.50	$5.57	$4.26	$5.29	$6.23	$8.34	$7.86	$8.49
EPS (diluted)	$4.35	$2.68	$9.34	$5.48	$4.20	$5.21	$6.17	$8.25	$7.76	$8.40
Diluted shares	378.50M	380.10M	380.30M	379.90M	380.30M	382.30M	382.20M	383.70M	385.60M	386.50M
Gross margin	66.3%	65.7%	65.7%	65.1%	63.1%	64.1%	62.8%	63.7%	63.9%	64.0%
Operating margin	19.2%	18.5%	18.7%	18.2%	15.5%	15.1%	15.4%	19.0%	16.3%	19.5%
Net margin	14.5%	8.2%	26.1%	14.0%	11.1%	11.7%	12.8%	15.4%	13.2%	12.9%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$3.32B	$2.54B	$3.62B	$4.34B	$2.94B	$2.94B	$1.84B	$2.97B	$3.65B	$4.01B
Short-term investments	—	—	—	$88.00M	$81.00M	$75.00M	$84.00M	$82.00M	$91.00M	$89.00M
Receivables	$1.97B	$2.20B	$2.33B	$2.89B	$2.70B	$3.02B	$3.56B	$3.77B	$3.99B	$4.04B
Inventory	$2.03B	$2.46B	$2.96B	$2.98B	$3.49B	$3.31B	$4.00B	$4.84B	$4.77B	$5.31B
Total current assets	$7.86B	$7.99B	$9.73B	$11.06B	$9.71B	$10.02B	$10.28B	$12.52B	$14.85B	$14.76B
Goodwill	$6.36B	$7.17B	$8.56B	$9.07B	$12.78B	$12.92B	$14.88B	$15.24B	$15.86B	$19.29B
Total assets	$20.43B	$22.20B	$27.23B	$30.17B	$34.33B	$34.63B	$36.88B	$39.91B	$42.97B	$47.84B
Total current liabilities	$3.15B	$3.48B	$4.81B	$4.40B	$5.04B	$4.55B	$6.30B	$7.92B	$7.62B	$7.79B
Short-term debt	$228.00M	$632.00M	$1.37B	$859.00M	$761.00M	$7.00M	$1.19B	$2.09B	$1.41B	$1.00B
Long-term debt	$6.69B	$6.59B	$8.49B	$10.23B	$13.23B	$12.47B	$11.86B	$10.90B	$12.19B	$14.86B
Total debt	$6.91B	$7.22B	$9.86B	$11.09B	$13.99B	$12.48B	$13.05B	$12.99B	$13.60B	$15.86B
Total liabilities	$10.88B	$12.22B	$15.50B	$17.36B	$21.25B	$19.75B	$20.27B	$21.32B	$22.34B	$25.42B
Shareholders' equity	$9.55B	$9.97B	$11.73B	$12.81B	$13.08B	$14.88B	$16.62B	$18.59B	$20.63B	$22.42B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$1.92B	$1.56B	$2.61B	$2.19B	$3.28B	$3.26B	$2.62B	$3.71B	$4.24B	$5.04B
Capital expenditures	$490.00M	$598.00M	$572.00M	$649.00M	$487.00M	$525.00M	$588.00M	$575.00M	$755.00M	$761.00M
Free cash flow	$1.43B	$961.00M	$2.04B	$1.54B	$2.79B	$2.74B	$2.04B	$3.14B	$3.49B	$4.28B
Investing cash flow	-$4.19B	-$1.61B	-$2.86B	-$1.46B	-$4.70B	-$859.00M	-$2.92B	-$962.00M	-$3.00B	-$4.87B
Financing cash flow	$2.26B	-$794.00M	$1.33B	$3.00M	-$11.00M	-$2.37B	-$749.00M	-$1.59B	-$525.00M	$113.00M
Dividends paid	$568.00M	$636.00M	$703.00M	$778.00M	$863.00M	$950.00M	$1.05B	$1.14B	$1.22B	$1.28B
Share buybacks	$13.00M	$230.00M	$300.00M	$307.00M	$0	$0	—	—	—	—
Stock-based compensation	$97.00M	$113.00M	$119.00M	$127.00M	$142.00M	$171.00M	$168.00M	$205.00M	$229.00M	$243.00M
Depreciation & amortization	$752.00M	$859.00M	$966.00M	$1.04B	$1.08B	$1.27B	$1.28B	$1.34B	$1.43B	$1.57B

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$5.82B	$5.24B	$5.42B	$5.49B	$6.44B	$5.87B	$6.02B	$6.06B	$7.17B	$6.02B	$6.59B	$6.52B
Cost of revenue	$2.11B	$1.91B	$2.01B	$1.98B	$2.26B	$2.12B	$2.18B	$2.21B	$2.54B	$2.21B	$2.09B	$2.27B
Gross profit	$3.70B	$3.33B	$3.42B	$3.52B	$4.17B	$3.74B	$3.84B	$3.85B	$4.63B	$3.81B	$4.50B	$4.25B
Research & development	$350.00M	$368.00M	$363.00M	$377.00M	$358.00M	$405.00M	$407.00M	$410.00M	$401.00M	$413.00M	$434.00M	$433.00M
Selling, general & admin	$1.91B	$1.84B	$1.83B	$1.89B	$2.12B	$2.30B	$2.08B	$2.04B	$2.23B	$2.28B	$2.23B	$2.31B
Operating income	$1.26B	$972.00M	$1.05B	$1.08B	$581.00M	$837.00M	$1.11B	$1.14B	$1.80B	$936.00M	$1.66B	$1.03B
Interest expense	—	—	$96.00M	$98.00M	$104.00M	$137.00M	$159.00M	$157.00M	$154.00M	$148.00M	$141.00M	$143.00M
Pre-tax income	$1.23B	$923.00M	$998.00M	$1.04B	$528.00M	$764.00M	$1.02B	$1.03B	$1.71B	$850.00M	$1.56B	$997.00M
Income tax	$83.00M	$135.00M	$173.00M	$209.00M	-$18.00M	$110.00M	$132.00M	$170.00M	$856.00M	$105.00M	$288.00M	$244.00M
Net income	$1.14B	$788.00M	$825.00M	$834.00M	$546.00M	$654.00M	$884.00M	$859.00M	$849.00M	$745.00M	$1.28B	$753.00M
EBITDA	$1.36B	$1.33B	$1.41B	$1.46B	$927.00M	$1.20B	$1.50B	$1.54B	$2.22B	$1.33B	$2.06B	$1.43B
EPS (basic)	$3.01	$2.07	$2.17	$2.18	$1.43	$1.71	$2.32	$2.25	$2.21	$1.95	$3.32	$1.97
EPS (diluted)	$2.98	$2.05	$2.14	$2.16	$1.41	$1.69	$2.29	$2.22	$2.20	$1.93	$3.30	$1.96
Diluted shares	0	385.10M	385.40M	385.60M	200.00K	386.40M	386.40M	386.70M	0	386.50M	386.00M	384.70M
Gross margin	63.7%	63.6%	63.0%	64.0%	64.9%	63.8%	63.8%	63.6%	64.5%	63.3%	68.3%	65.2%
Operating margin	21.6%	18.5%	19.4%	19.7%	9.0%	14.3%	18.5%	18.7%	25.2%	15.5%	25.2%	15.9%
Net margin	19.7%	15.0%	15.2%	15.2%	8.5%	11.1%	14.7%	14.2%	11.8%	12.4%	19.4%	11.5%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$2.97B	$2.33B	$1.87B	$3.85B	$3.65B	$2.32B	$2.38B	$3.26B	$4.01B	$2.88B	$3.39B	$3.27B
Short-term investments	$82.00M	$77.00M	$83.00M	$84.00M	$91.00M	$89.00M	$89.00M	$87.00M	$89.00M	$87.00M	$85.00M	$0
Receivables	$3.77B	$3.47B	$3.62B	$3.74B	$3.99B	$3.96B	$3.92B	$3.64B	$4.04B	$3.57B	$3.74B	$3.69B
Inventory	$4.84B	$5.03B	$5.04B	$5.29B	$4.77B	$5.11B	$5.29B	$5.37B	$5.31B	$5.42B	$5.52B	$5.75B
Total current assets	$12.52B	$11.89B	$11.64B	$14.67B	$14.85B	$13.02B	$13.00B	$13.71B	$14.76B	$13.34B	$14.42B	$14.18B
Goodwill	$15.24B	$15.35B	$15.41B	$16.40B	$15.86B	$19.09B	$19.18B	$19.26B	$19.29B	$19.19B	$19.58B	$19.33B
Total assets	$39.91B	$39.40B	$39.13B	$43.83B	$42.97B	$46.01B	$46.33B	$47.06B	$47.84B	$46.29B	$47.93B	$47.25B
Total current liabilities	$7.92B	$6.96B	$6.93B	$7.67B	$7.62B	$7.93B	$7.29B	$7.41B	$7.79B	$6.32B	$6.68B	$6.50B
Short-term debt	$2.09B	$2.06B	$2.10B	$2.16B	$1.41B	$2.40B	$1.75B	$1.75B	$1.00B	$499.00M	$750.00M	$754.00M
Long-term debt	$10.90B	$10.81B	$10.13B	$13.32B	$12.19B	$14.38B	$14.83B	$14.85B	$14.86B	$14.22B	$14.19B	$14.18B
Total debt	$12.99B	$12.87B	$12.22B	$15.48B	$13.60B	$16.78B	$16.58B	$16.59B	$15.86B	$14.72B	$14.94B	$14.93B
Total liabilities	$21.32B	$20.23B	$19.37B	$23.68B	$22.34B	$25.08B	$25.14B	$25.27B	$25.42B	$23.31B	$23.94B	$23.79B
Shareholders' equity	$18.59B	$19.17B	$19.76B	$20.15B	$20.63B	$20.93B	$21.19B	$21.79B	$22.42B	$22.98B	$23.99B	$23.46B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$1.53B	$204.00M	$633.00M	$1.47B	$1.93B	$250.00M	$1.11B	$1.54B	$2.14B	$581.00M	$1.26B	$1.46B
Capital expenditures	$145.00M	$167.00M	$152.00M	$170.00M	$266.00M	$123.00M	$183.00M	$187.00M	$268.00M	$166.00M	$202.00M	$237.00M
Free cash flow	$1.38B	$37.00M	$481.00M	$1.30B	$1.67B	$127.00M	$928.00M	$1.35B	$1.88B	$415.00M	$1.06B	$1.22B
Investing cash flow	-$152.00M	-$408.00M	-$117.00M	-$2.17B	-$303.00M	-$4.14B	-$104.00M	-$321.00M	-$305.00M	-$185.00M	-$639.00M	-$187.00M
Financing cash flow	-$286.00M	-$418.00M	-$966.00M	$2.65B	-$1.79B	$2.53B	-$989.00M	-$339.00M	-$1.09B	-$1.51B	-$95.00M	-$1.39B
Dividends paid	$285.00M	$304.00M	$305.00M	$305.00M	$305.00M	$320.00M	$321.00M	$322.00M	$321.00M	$337.00M	$337.00M	$338.00M
Stock-based compensation	$40.00M	$87.00M	$46.00M	$51.00M	$45.00M	$84.00M	$49.00M	$62.00M	$48.00M	$87.00M	$54.00M	$67.00M
Depreciation & amortization	$101.00M	$355.00M	$354.00M	$371.00M	$346.00M	$361.00M	$387.00M	$402.00M	$417.00M	$397.00M	$404.00M	$397.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.